| Abstract: |
In one aspect, a coronavirus is treated by administering a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof. In another aspect, oxidative stress is reduced in an individual suffering from a coronavirus by administering a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof. In another aspect, mitochondrial reactive oxygen species (mtROS) are inhibited in an individual suffering from a coronavirus by administering a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof. In one example, the coronavirus is Covid-19. |
| Inventor: |
Williams, Jonnie R. (Sarasota, FL, US) |
| Applicant: |
MyMD Pharmaceuticals, Inc. (Tampa, FL, US) |
| Face Assignee: |
N/A |
| Filed: |
2020-02-17 |
| Issued: |
2020-06-11 |
| Claims: |
19 |
|
US20200179367
|
1. A method of treating a coronavirus comprising administering to an individual in need thereof a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
(5)
(0)
|
|
13. A method of inhibiting mitochondrial reactive oxygen species (mtROS) in an individual suffering from a coronavirus comprising administering to the individual a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
(5)
(0)
|
|
19. A method of inhibiting tumor necrosis factor-alpha (TNF-α) levels in an individual suffering from a coronavirus comprising administering to the individual a pharmaceutical composition containing a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
(5)
(0)
|
|
